Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  17,515 results for ""Hepatocellular carcinoma""

Your Filters

Subject : cell proliferation
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

In Vitro Investigation of the Anti-Hepatocellular Carcinoma Activity of Peptides Derived From Quinoa (Chenopodium quinoa Willd) Bran.

  • Authors : Shi J; Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, 030006, Taiyuan, China.; Bi C

Subjects: Chenopodium quinoa*/Chenopodium quinoa*/Chenopodium quinoa*/chemistry ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy

  • Source: Plant foods for human nutrition (Dordrecht, Netherlands) [Plant Foods Hum Nutr] 2025 Jan 06; Vol. 80 (1), pp. 28. Date of Electronic Publication: 2025 Jan 06.Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8803554 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Sohlh2 Promotes the Progression of Hepatocellular Carcinoma via TGM2-Mediated Autophagy.

  • Authors : Liu X; Key Laboratory of The Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Zhang R

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Molecular carcinogenesis [Mol Carcinog] 2025 Jan; Vol. 64 (1), pp. 138-151. Date of Electronic Publication: 2024 Oct 22.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CircSCMH1 Accelerates Sorafenib Resistance in Hepatocellular Carcinoma by Regulating HN1 Expression via miR-485-5p.

  • Authors : Li M; Department of Surgery and Oncology, The First Affiliated Hospital of Shenzhen University Health Science Center, No. 3002 Sungang West Road, Futian District, Shenzhen, Guangdong, China.; Pang X

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology

  • Source: Molecular biotechnology [Mol Biotechnol] 2025 Jan; Vol. 67 (1), pp. 304-316. Date of Electronic Publication: 2024 Feb 19.Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma.

  • Authors : Min X; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 25/Ln 2200 Xietu Road, Shanghai, 200032, China.; Lin F

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/metabolism ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/genetics ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology

  • Source: Cellular oncology (Dordrecht, Netherlands) [Cell Oncol (Dordr)] 2024 Dec; Vol. 47 (6), pp. 2247-2264. Date of Electronic Publication: 2024 Nov 21.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Inhibition of XPR1-dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?

  • Authors : Liao ZQ; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, College of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, China.; Institute for Advanced Study, Nanchang University, Nanchang, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics

  • Source: Molecular carcinogenesis [Mol Carcinog] 2024 Dec; Vol. 63 (12), pp. 2332-2345. Date of Electronic Publication: 2024 Aug 13.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway.

  • Authors : Ding Y; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Gannan Medical University,, Ganzhou, Jiangxi, 341000, China.; Wang X

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics

  • Source: Journal of molecular histology [J Mol Histol] 2024 Dec; Vol. 55 (6), pp. 1107-1120. Date of Electronic Publication: 2024 Aug 28.Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 101193653 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

hsa_circ_0072309 Inhibits Oncogenesis in Hepatocellular Carcinoma by Epigenetic Activation of its Host Gene.

  • Authors : Wang T; Department of Interventional Therapy, Yantai Yuhuangding Hospital, NO.20 East Yuhuangding Road, 264000, Yantai, China.; Du Y

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Cell biochemistry and biophysics [Cell Biochem Biophys] 2024 Dec; Vol. 82 (4), pp. 3251-3263. Date of Electronic Publication: 2024 Sep 16.Publisher: Humana Press Country of Publication: United States NLM ID: 9701934 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

KRT80 in hepatocellular carcinoma plays oncogenic role via epithelial-mesenchymal transition and PI3K/AKT pathway.

  • Authors : Hua R; Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Department of Gastrointestinal Surgery, Affiliated Hospital of Nantong University, Nantong, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: IUBMB life [IUBMB Life] 2025 Jan; Vol. 77 (1), pp. e2925. Date of Electronic Publication: 2024 Nov 21.Publisher: Published for the International Union of Biochemistry and Molecular Biology by Taylor & Francis Country of Publication: England NLM ID: 100888706

Record details

Read More Add to Saved list
×
Academic Journal

Delta-Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway.

  • Authors : Liu X; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu Province, People's Republic of China.; Li T

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics

  • Source: Molecular carcinogenesis [Mol Carcinog] 2025 Jan; Vol. 64 (1), pp. 176-191. Date of Electronic Publication: 2024 Oct 28.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Glabridin inhibits proliferation and migration in hepatocellular carcinoma by regulating multi-targets.

  • Authors : Wang F; College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China. Electronic address: .; Yuan C

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2025 Feb 10; Vol. 338 (Pt 1), pp. 119022. Date of Electronic Publication: 2024 Nov 06.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  17,515 results for ""Hepatocellular carcinoma""